mean±1 SD values of 51±9% (N), 30±9% (C), and 34±10 (N), 48±14% (C), respectively. As demonstrated with a latex bead-binding technique, N PMN failed to redistribute adhesion sites to the cell's tail under the same experimental conditions; in 21 N samples studied, restricted unipolar binding occurred in 33±8% (fMLP) or 37± 7% (C5a) ofPMN in contrast to C values of 70% (fMLP), or 71% (C5a), P < 0.001. Similar findings were observed when PMN were preincubated with colchicine (25 ,ug/ml); expected diminished adherence scores (compared with base-line values) were demonstrated with C PMN but not with N cells, P < 0.01. Additionally colchicine-induced redistribution of adhesion sites as was observed with C samples (72±14% unipolar binding) was significantly (P < 0.001) less among N PMN (31±11% unipolar binding). These investigations indicate that CF sensory mechanisms of N PMN are normal, compared with healthy adult or maternal controls. Diminished stimulated locomotion of the N PMN may be functionally related to reduced modulation ofcell adhesiveness by chemotactic stimulation.
INTRODUCTION Previous investigations of neonatal polymorphonuclear leukocyte (PMN)1 motility have consistently
demonstrated defects of both the humoral and cellular contributions to chemotactic function (1) (2) (3) (4) (5) (6) (7) (8) (9) . Although it is generally agreed that the neonatal PMN is insufficient in its directed migratory response to chemotactic stimuli, the nature of this defect is not understood, and the underlying mechanisms have not been characterized. To allow a better understanding of the biological basis of impaired stimulated locomotion, studies of chemotactic factor (CF) "sensory" function, morphologic and adhesive properties of healthy newborn PMN were carried out with the aid of recently developed techniques (10) (11) (12) (13) . Investigations reported here suggest that CF sensory functions of the neonatal PMN do not account for their impaired directed migration. In contrast, profound abnormalities of CF or colchicine-induced alterations of PMN adherence and morphology have been identified. Specifically, an impaired redistribution of cell surface adhesion sites and diminished uropod formation by neonatal PMN have been observed and appear to be functionally related to their diminished migratory responses. These findings further extend our previous observations demonstrating the clinicopathologic importance of abnormalities of PMN adherence and morphology (14) . In addition, they suggest that interrelated influences of CF on the configurational and adherence properties of PMN are critical functional determinants of their stimulated locomotion.
METHODS
Blood samples. 5-60 ml of heparinized venous blood was drawn from the placentas of normal full term (n = 50) or premature (n = 10) infants within 5 min of birth. Equivalent or larger samples (100-200 ml) were drawn from healthy maternal pairs or adult laboratory donors. All blood samples were processed for studies of PMN function <10 min after phlebotomy. Informed consent was obtained from all patients before obtaining blood samples.
Preparation of CF. Chemoattractant solutions were prepared for use in PMN mobility, adherence, shape change, latex bead binding, chemiluminescence (CL) Stock solutions of N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe) ( (11, 14) .
A low molecular weight chemotactic factor, referred to as C5a in this manuscript, was prepared from activated human sera by the method of Gallin and Rosenthal (15) . This reagent as previously demonstrated in our laboratory was shown to exert maximal chemotactic effects at a concentration of 40 ,ug protein/ml (12, 14) .
Bacterial chemotactic factor (BCF) was derived from Escherichia coli UCLA 0101 as previously described (14); a 1:2 dilution of this reactant effected maximal directed PMN migratory responses.
Isolation of PMN. Purified populations of PMN were obtained by the gradient centrifugation technique of Boyum (16). 5 ml of heparinized (10 U/ml) whole blood was layered over an equal volume of a Ficoll-Hypaque mixture (24 parts of Ficoll, Sigma Chemical Co.; 10 parts Hypaque, Winthrop Laboratories, New York). After centrifugation at 300 g for 30 min at 4°C, the interface layer was removed and the PMN/ erythrocyte button was resuspended in 10 ml of DPBS. PMN were then isolated by dextran sedimentation, washed twice and resuspended in DPBS. Cell viability as determined by trypan blue dye exclusion was >95%. Final PMN suspensions contained >85% PMN. Minimal platelet contamination in these suspensions was observed and the erythrocyte:PMN ratio was <3:1. Final cell preparations were adjusted to a concentration of 107 or 108 PMN/ml DPBS. For use in CL or f-Met-Leu-[3H]Phe binding studies, erythrocyte contamination was eliminated by hypotonic lysis of suspensions with distilled water (14) .
Preliminary studies were performed to exclude the possibility that significant degranulation was occurring under experimental conditions chosen to evaluate motility, adherence, and morphology. PMN suspensions (5 x 106/ml) were stimulated with the maximum f-Met-Leu-Phe concentration (10 nM) used in our studies for 10 min at room temperature or at 37°C. Following centrifugation, PMN were lysed by suspending the cell button in Triton-X (10% in water) before repeated (five times) freezing and thawing. Supernates of lysed preparations and the supernates of the original cell suspensions were assayed for lysozyme activity, as previously described, with the substrate, Micrococcus lysodeikticus (17) . For both neonatal and adult control suspensions, minimal (<2 ,ug/ml) or no lysozyme activity was detectable in supernates of unstimulated or f-Met-Leu-Phe-stimulated cell suspensions. Lysed cell preparations demonstrated [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ,ug/ml lysozyme activity based on a standardized urine sample obtained from a leukemic patient. In all cases, >90% of total lysozyme of cell suspensions was detected within PMN after f-Met-Leu-Phe stimulation.
Assessment of neutrophil motility. Neutrophil motility into micropore filters was assessed by a modified Boyden technique with blind well chambers (Neuro Probe, Inc., Bethesda, Md.) and 3-,um millipore size filters (Millipore Corp., Bedford, Mass.) as previously described (14) . Behavior of neutrophil populations in this system was evaluated in two ways: (a) the distribution of cells in the filters was evaluated at various times with an Optimax Image Analyzer, (Optimax, Inc., Colmar, Pa.) after loading the chemotaxis chambers and (b) the depths at which only two cells were in focus in one high power (x40) field ("leading front") were measured after incubation periods of (12) .
Assessment of neutrophil adhesiveness. Chambers consisting of two 25-nm round cover glasses, rubber gaskets, and specially milled brass plates were used as previously described (13 ,um) (Sigma Chemical Co.) were suspended in a solution of 1% human serum albumin and DPBS for 2 min at room temperature, washed, and resuspended in DPBS. Control or patient cells were exposed to 1% albumin-coated latex beads (ACLB) suspensions (vol/vol) for 5 min at room temperature as previously described (13, 14) . ACLB binding was assessed after exposure of cells to chemotactic factors or colchicine under varying experimental conditions. Cells in suspensions were then fixed in 1.5% glutaraldehyde and examined with phase contrast optics. Results were expressed as the percentage of cells demonstrating unipolar binding (beads restricted to the uropod region of the cell) or generalized (random) binding patterns (13, 14) . Luminol-enhanced CL assay. The evolution of light or CL by neutrophils after metabolic activation by f-Met-Leu-Phe was quantitated as previously described (19) . CL activity was determined over a 12-min interval after the incorporation of 5 x 106 PMN and f-Met-Leu-Phe at concentrations ranging from 0.1 to 10 nM.
Scanning electron microscopy procedures. Unstimulated and chemotactically stimulated neutrophils were fixed in a solution of 2% glutaraldehyde in 0.1 M Pipes buffer (piperazone-N, N' bis-2-ethane sulfonic acid) at pH 7.4 for 1 h. Cells were then washed three times with Pipes buffer, resuspended for 1 h in this buffer solution containing 1% OSSO4, then dehydrated by a graded series of acetone washes with a final three changes of 100% acetone. After drying out CO2 in a Bowmar Critical Point Drying apparatus (Bowmar Instrument Corp., Fort Wayne, Ind.), samples were sputter coated with 8 nm gold palladium with a Denton Desk-i apparatus (Denton Vacuum Inc., Cherry Hill, N. J.), and then examined with a JEOL 100 CX electron microscope equipped with a scanning attachment and operating at 25 kV (JEOL USA, Electron Optics Div., Medford, Mass.). Micrographs were recorded from a 2,000-line cathode ray tube on Polaroid P/N 55 film (Eastman Kodak Co., Rochester, N. Y.).
RESULTS
Assessment of PMN motility. The directed migratory responses of PMN obtained from 22 neonates are illustrated and compared with those of 12 healthy adult controls in Figs. 1 and 2. Leading front values ( Fig. 1 ) of neonatal cells were significantly (P < 0.01) diminished, compared with controls in response to C5a, fMet-Leu-Phe, and BCF, which confirms previous reports (1) (2) (3) CF-induced CL. A luminol-enhanced CL assay was used to evaluate the threshold and maximally effective concentrations off-Met-Leu-Phe necessary to stimulate PMN oxidative metabolism (14) . As shown (Fig. 6) Fig. 9 . The saturating concentration of PMN suspensions of both study populations was between 30 and 100 nM, with one-half maximal binding occurring at a concentration of -10-30 nM. As determined in additional studies, binding was tem- perature dependent; saturable binding at 370C for both neonatal and control cells was -eight-fold that at 40C. Finally, PMN of both study groups incubated at saturating concentrations (100 nM) of f-Met-Leu-[3H]Phe for 12 min at 37°C demonstrated an equivalent extent and slow rate of dissociation of bound peptide when "chased" with an excess of unlabeled peptide; as was also observed with less than saturating concentrations (Fig. 7) , -70% of bound peptide remained cell associated. values were comparable to adult control values (data not shown).
As previously reported (13, 14) , adherence of normal PMN diminishes sharply after sequential exposure (restimulation) to increasing concentrations of CF. This phenomenon appears to be the result of a restricted redistribution of adhesion sites on the cell uropod (13) . These observations were confirmed in the adult control population studied here ( Fig. 10 and Table II Distribution of PMN adhesion sites. To explore the relationship of impaired motility of neonatal PMN to observed abnormalities of adhesive function, the distribution of adhesion sites was assessed under identical experimental conditions by means of a previously described technique (13) . Essentially no binding of ACLB to unstimulated cells was observed for any of the study populations. After a single CF exposure, binding of several ACLB per cell was generally observed. Among the three study groups, a comparable generalized (random) distribution of ACLB binding was seen on -75% of the cells. Unipolar binding of ACLB (Fig. 11) was identified in only a small percentage of cells exposed to C5a or f-Met-Leu-Phe: for neonates, mean+SD = 25±+6% (C5a), 21±13% (f-MetLeu-Phe); for adult control, mean = 27±3% (C5a), 23±9% (f-Met-Leu-Phe); for maternal control, mean = 19±3% (f-Met-Leu-Phe). Since neonatal cells had a reduced incidence of uropods, unipolar binding was considered present if ACLB were clustered at the pole of the cell opposite the lamellipodia. This was quite distinct in stimulated bipolar neonatal cells (Fig. 1 lb) .
Striking abnormalities were observed for neonatal PMN under conditions of sequential CF exposure (Fig. 12) . As shown, a second (higher) CF stimulus markedly enhanced the unipolar binding of adult or maternal control PMN. But, a redistribution of binding sites for ACLB to the uropod of neonatal cells was the cell surface initiate a sequence of events leading to stimulated or directed migration (22) . The precise nature of the interaction of CF with membrane receptors has received considerable attention (10, 11, (22) (23) (24) (10, 23, 24) , the majority of peptide bound at 37°C was irreversibly cell associated. Approximately 70% of total binding of peptide was not dissociable when PMN suspensions were "chased" with an excess (1,000-fold) ofunlabeled peptide after 12 min of incubation at 37°C. Neonatal and adult cells reacted comparably, which further supports the contention that the kinetics of f-Met peptide-receptor interactions are normal in the neonate. Further studies will be necessary, however, to completely characterize the CF receptors of neonatal cells such as the CF modulation of receptor function (e.g., down regulation) and the activity of receptors for other chemotactic factors.
Further confirmation of normal CF sensory function of neonatal PMN is suggested by our observations that similar threshold concentrations of f-Met-LeuPhe were required to initiate oxidative metabolism (CL) (>1 nM) and effect activated bipolar morphology of cells in suspension (0.1 nM), when compared with Polymorphonuclear Leukocyte Mobility and Adherence Propertiescontrols. Dose-response experiments also demonstrated comparable concentrations effecting maximal CL evolution or bipolar morphology. Slightly increased peak CL values were noted for neonatal cells exposed to 10 nM f-Met-Leu-Phe (P > 0.05, compared with adult PMN). This may reflect the well-recognized enhanced metabolic activity of neonatal PMN (25) .
Although neonatal cells exhibited some normal CFstimulated functions (such as shape change), others were distinctly unlike adult cells. Uropod formation was low and cellular adhesiveness was only marginally influenced by CF stimulation. Interrelated influences of CF on PMN morphology, adhesive properties, and motility have been strongly supported by recent studies (12) (13) (14) (26) (27) (28) (29) (30) (31) (32) (33) (34) . The neonatal PMN appears to represent an example of an abnormality in these interrelationships. Whereas unstimulated neonatal PMN exhibit adherence comparable to adult cells (Table I , Fig. 10 ) (35) , the expected increments of PMN adherence for protein-coated glass substrates after a single CF exposure were generally not observed with neonatal cells. Single CF stimulus values were essentially unchanged from base-line values in contrast to the increased adherence of adult cells. The neonate thus is a naturally occurring example of dissociation of CF-induced shape change and adherence. This dissociation can be produced pharmacologically with 0.2 nM N-Tosyl-Lysine chloromethyl ketone, which blocks the increase in adherence but not shape change, and with cytochalasin B, which blocks shape change but not the increase in adhesiveness (12, 13) . It would be of considerable interest to determine whether the decreased response of neonatal cells to CF also extends to other factors shown to modulate PMN adherence such as thromboxane A2 (36) or cyclic AMP (37) .
The precise nature of cell-substrate interactions have been shown to influence the characteristics of cell translocation in vitro, and the clinical significance of PMN adherence properties in host response to infection in gaining increased recognition (12-14, 33, 38) . It (13, 14) . An increase in CF stimulation causes a drop in cell adhesiveness. This appears to be due to a restricted distribution of adhesion sites, since cells treated in this manner attach to proteincoated surfaces only by the tip of the uropod, and binding sites for ACLB are restricted to the cell uropod (13) . The CF-induced adhesion sites flow to the uropod with an increased CF concentration. These events appear to be permitted by the disassembly of microtubules, since colchicine causes essentially the same effect as a single-step increment in the concentration of CF (21, (38) (39) (40) . We attempted to determine whether this mechanism was normal in neonatal cells, and found clear evidence that it is not. Neonatal cells showed little change in adhesiveness with either sequential increments in CF stimulation or colchicine treatment. They also exhibited a significantly reduced ability to move binding sites for ACLB to the cell's tail. Our findings suggest a basic cellular defect involving the movement of surface moieties to the uropod of neonatal PMN as well as an abnormality in CF modulation of adherence. If one can assume that the colchicine levels used in our study disrupted the microtubule-linked anchoring of surface moieties, it appears that neonatal cells have an abnormality in the movement of these substances in the membrane. The basis for this decreased fluidity is not clear but may be linked to the decreased deformability observed in immature neutrophils (5, 41) . We recently reported similar investigations in a child with severe recurrent staphylococcal infections and profoundly diminished leukocyte motility in vitro (14) . In contrast to neonatal PMN, his cells showed normal shape change and decrease in adherence after exposure to colchicine, as well as normal movement of binding sites for ACLB for one pole of the cell. Like the neonatal cells, however, CF stimulation failed to activate this mechanism, although it evoked a normal CL response. Thus, the mobility ofmembrane moieties was normal but CF stimulation was defective and did not permit this mobility to occur.
Our current study indicates that the healthy neonate provides a readily accessible clinical model in which to explore possible mechanisms of impaired PMN migration as well as functional requirements for normal PMN locomotion. Diminished leukocyte mobilization in neonates is thought to contribute significantly to their enhanced susceptibility to microbial invasion (5) . Although it presumably occurs on a developmental basis, studies to further define the mechanism ofthe abnormalities of cell locomotion will be necessary to allow future approaches to the pharmacologic modulation of PMN 
